Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease

被引：0
作者：
Nasser Ebrahimi Daryani
Maryam Sadr
Shirin Moossavi
Sepideh Shahkarami
Samaneh Soltani
Elham Farhadi
Nima Rezaei
机构：
[1] Tehran University of Medical Sciences,Department of Gastroenterology and Hepatology
[2] Tehran University of Medical Sciences,Molecular Immunology Research Center, Department of Immunology, School of Medicine
[3] Tehran University of Medical Sciences,Digestive Oncology Research Center, Digestive Disease Research Institute
[4] Iran University of Medical Sciences,Hematology Department, School of Allied Medical Science
[5] Tehran University of Medical Sciences,Research Center for Immunodeficiencies, Children’s Medical Center Hospital
来源：
Digestive Diseases and Sciences | 2015年 / 60卷
关键词：
Interleukin-1α; Interleukin-1β; Single nucleotide polymorphism; Inflammatory bowel diseases; Crohn’s disease; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1389 / 1395
页数：6
相关论文
共 194 条
[1]  
Abraham C(2009)Inflammatory bowel disease N Engl J Med 361 2066-2078
[2]  
Cho JH(2013)Opposing functions of classic and novel IL-1 family members in gut health and disease Front Immunol 4 181-45
[3]  
Lopetuso LR(2000)Increased small bowel epithelial turnover in interleukin-1 receptor knockout mice Ann Surg 232 42-258
[4]  
Chowdhry S(2012)Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine J Exp Med 209 251-2275
[5]  
Pizarro TT(2013)MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling Proc Natl Acad Sci USA 110 2270-3357
[6]  
Wolf SE(2010)IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function Eur J Immunol 40 3347-2477
[7]  
Debroy MA(2013)Myeloid-derived suppressor cells in the inflammatory bowel diseases Inflamm Bowel Dis 19 2468-329
[8]  
Ikeda H(2004)Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease Clin Exp Immunol 138 323-442
[9]  
Shaw MH(1998)Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD) Clin Exp Immunol 112 435-689
[10]  
Kamada N(1990)Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease Gut 31 686-838
12345678910